185 related articles for article (PubMed ID: 25628149)
1. Safe and effective treatment of spontaneous neoplasms with interleukin 12 electro-chemo-gene therapy.
Cutrera J; King G; Jones P; Kicenuik K; Gumpel E; Xia X; Li S
J Cell Mol Med; 2015 Mar; 19(3):664-75. PubMed ID: 25628149
[TBL] [Abstract][Full Text] [Related]
2. Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice.
Kishida T; Asada H; Itokawa Y; Yasutomi K; Shin-Ya M; Gojo S; Cui FD; Ueda Y; Yamagishi H; Imanishi J; Mazda O
Mol Ther; 2003 Nov; 8(5):738-45. PubMed ID: 14599806
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of tumor-targeted interleukin 12 gene therapy in treated and non-treated, metastatic lesions.
Cutrera J; King G; Jones P; Kicenuik K; Gumpel E; Xia X; Li S
Curr Gene Ther; 2015; 15(1):44-54. PubMed ID: 25429465
[TBL] [Abstract][Full Text] [Related]
4. Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs.
Reed SD; Fulmer A; Buckholz J; Zhang B; Cutrera J; Shiomitsu K; Li S
Cancer Gene Ther; 2010 Jul; 17(7):457-64. PubMed ID: 20150931
[TBL] [Abstract][Full Text] [Related]
5. Intratumoural interleukin 12 gene therapy stimulates the immune system and decreases angiogenesis in dogs with spontaneous cancer.
Cicchelero L; Denies S; Haers H; Vanderperren K; Stock E; Van Brantegem L; de Rooster H; Sanders NN
Vet Comp Oncol; 2017 Dec; 15(4):1187-1205. PubMed ID: 27506827
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral bleomycin and IL-12 electrochemogenetherapy for treating head and neck tumors in dogs.
Cutrera J; Torrero M; Shiomitsu K; Mauldin N; Li S
Methods Mol Biol; 2008; 423():319-25. PubMed ID: 18370210
[TBL] [Abstract][Full Text] [Related]
7. Bleomycin/interleukin-12 electrochemogenetherapy for treating naturally occurring spontaneous neoplasms in dogs.
Reed SD; Fulmer A; Buckholz J; Zhang B; Cutrera J; Shiomitsu K; Li S
Cancer Gene Ther; 2010 Aug; 17(8):571-8. PubMed ID: 20414325
[TBL] [Abstract][Full Text] [Related]
8. Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy.
Li S; Zhang X; Xia X
J Natl Cancer Inst; 2002 May; 94(10):762-8. PubMed ID: 12011227
[TBL] [Abstract][Full Text] [Related]
9. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model.
Chuang TF; Lee SC; Liao KW; Hsiao YW; Lo CH; Chiang BL; Lin XZ; Tao MH; Chu RM
Int J Cancer; 2009 Aug; 125(3):698-707. PubMed ID: 19431145
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.
Daud AI; DeConti RC; Andrews S; Urbas P; Riker AI; Sondak VK; Munster PN; Sullivan DM; Ugen KE; Messina JL; Heller R
J Clin Oncol; 2008 Dec; 26(36):5896-903. PubMed ID: 19029422
[TBL] [Abstract][Full Text] [Related]
11. Genetically modified tumour vaccines producing IL-12 augment chemotherapy of HPV16-associated tumours with gemcitabine.
Mikyšková R; Indrová M; Símová J; Bieblová J; Bubeník J; Reiniš M
Oncol Rep; 2011 Jun; 25(6):1683-9. PubMed ID: 21424130
[TBL] [Abstract][Full Text] [Related]
12. Bleomycin--electrical pulse delivery: electroporation therapy-bleomycin--Genetronics; MedPulser-bleomycin--Genetronics.
Drugs R D; 2004; 5(5):293-6. PubMed ID: 15357628
[TBL] [Abstract][Full Text] [Related]
13. Gene electrotransfer of IL-2 and IL-12 plasmids effectively eradicated murine B16.F10 melanoma.
Komel T; Bosnjak M; Kranjc Brezar S; De Robertis M; Mastrodonato M; Scillitani G; Pesole G; Signori E; Sersa G; Cemazar M
Bioelectrochemistry; 2021 Oct; 141():107843. PubMed ID: 34139572
[TBL] [Abstract][Full Text] [Related]
14. Non-viral in vivo immune gene therapy of cancer: combined strategies for treatment of systemic disease.
Tangney M; Casey G; Larkin JO; Collins CG; Soden D; Cashman J; Whelan MC; O'Sullivan GC
Cancer Immunol Immunother; 2006 Nov; 55(11):1443-50. PubMed ID: 16612593
[TBL] [Abstract][Full Text] [Related]
15. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma.
Lucas ML; Heller R
DNA Cell Biol; 2003 Dec; 22(12):755-63. PubMed ID: 14683586
[TBL] [Abstract][Full Text] [Related]
16. The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck.
Bloom DC; Goldfarb PM
Eur J Surg Oncol; 2005 Nov; 31(9):1029-35. PubMed ID: 16150565
[TBL] [Abstract][Full Text] [Related]
17. Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo.
Goto T; Nishi T; Kobayashi O; Tamura T; Dev SB; Takeshima H; Kochi M; Kuratsu J; Sakata T; Ushio Y
Mol Ther; 2004 Nov; 10(5):929-37. PubMed ID: 15509510
[TBL] [Abstract][Full Text] [Related]
18. Candidate genes associated with tumor regression mediated by intratumoral IL-12 electroporation gene therapy.
Li S; Xia X; Mellieon FM; Liu J; Steele S
Mol Ther; 2004 Mar; 9(3):347-54. PubMed ID: 15006601
[TBL] [Abstract][Full Text] [Related]
19. Tailor-made fibroblast-specific and antibiotic-free interleukin 12 plasmid for gene electrotransfer-mediated cancer immunotherapy.
Kamensek U; Tesic N; Sersa G; Kos S; Cemazar M
Plasmid; 2017 Jan; 89():9-15. PubMed ID: 27890562
[TBL] [Abstract][Full Text] [Related]
20. IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice.
Harada N; Shimada M; Okano S; Suehiro T; Soejima Y; Tomita Y; Maehara Y
J Immunol; 2004 Dec; 173(11):6635-44. PubMed ID: 15557154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
